Evidence map›Paper›PMID 31960596›Full record

ArticlePhysiological reports2020

Galanin suppresses visceral afferent responses to noxious mechanical and inflammatory stimuli.

Toni S Taylor, Parvesh Konda, Sarah S John, David C Bulmer, James R F Hockley, Ewan St John Smith

Abstract read
In one paragraph

Article in Physiological reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Biochemical and Physiological Effects of Galanin in Health and Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toni S TaylorDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Parvesh KondaDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Sarah S JohnDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
David C BulmerDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
James R F HockleyDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Ewan St John SmithDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2699-1979

Funding

Biotechnology and Biological Sciences Research Council BB/R006210/1
6 · The paper itself

Abstract

Galanin is a neuropeptide expressed by sensory neurones innervating the gastrointestinal (GI) tract. Galanin displays inhibitory effects on vagal afferent signaling within the upper GI tract, and the goal of this study was to determine the actions of galanin on colonic spinal afferent function. Specifically, we sought to evaluate the effect of galanin on lumbar splanchnic nerve (LSN) mechanosensitivity to noxious distending pressures and the development of hypersensitivity in the presence of inflammatory stimuli and colitis. Using ex vivo electrophysiological recordings we show that galanin produces a dose-dependent suppression of colonic LSN responses to mechanical stimuli and prevents the development of hypersensitivity to acutely administered inflammatory mediators. Using galanin receptor (GalR) agonists, we show that GalR1 activation, but not GalR2/3 activation, suppresses mechanosensitivity. The effect of galanin on colonic afferent activity was not observed in tissue from mice with dextran sodium sulfate-induced colitis. We conclude that galanin has a marked suppressive effect on colonic mechanosensitivity at noxious distending pressures and prevents the acute development of mechanical hypersensitivity to inflammatory mediators, an effect not seen in the inflamed colon. These actions highlight a potential role for galanin in the regulation of mechanical nociception in the bowel and the therapeutic potential of targeting galaninergic signaling to treat visceral hypersensitivity.

Indexed as

AnimalsColonFemaleGalaninMaleMiceMice, Inbred C57BLNeurons, AfferentNociceptionReceptors, GalaninSplanchnic NervesStress, MechanicalVisceral PainGalaninReceptors, Galanincolongalaninhypersensitivityinflammationmechanosensitivityvisceral pain

Identifiers

PMID31960596
PMCPMC6971316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.